We strive to develop medications that do only 1 or 2 things (ie, blocking serotonin reuptake or blocking D2 and 5HT2a receptors) and do nothing else. We assume that all other mechanisms of action ...

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of ...

It may be noted that a minister cannot disown the stance of his ministry with regard to important policy or executive ...

Multiple endocrine neoplasia type 1 (MEN1) is a hereditary tumor syndrome ... and transcription regulation Understanding the mechanism of action for menin will eventually provide targets for ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World ...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, ...

“The only therapeutic vaccine that's approved is Provenge (sipuleucel-T) which is a completely different mechanism so we don ... is evaluating Akeega, a dual action tablet combining niraparib ...

NDAQ:COSM) Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at ...

3-dioxygenase 1 (IDO; IDO1; INDO) is a rate-limiting enzyme that metabolizes the essential amino acid, tryptophan, into downstream kynurenines. Canonically, the metabolic depletion of tryptophan ...